FDA Approves Weight-Loss Drug Developed By La Jolla Company

U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc., based in La Jolla, California. The Food and Drug …





via Get Fit Bookmark http://ift.tt/1nS1ztG

via Tumblr http://ift.tt/1pZ2qYP